144 related articles for article (PubMed ID: 29303375)
1. Structure optimisation to improve the delivery efficiency and cell selectivity of a tumour-targeting cell-penetrating peptide.
Cao XW; Yang XZ; Du X; Fu LY; Zhang TZ; Shan HW; Zhao J; Wang FJ
J Drug Target; 2018 Nov; 26(9):777-792. PubMed ID: 29303375
[TBL] [Abstract][Full Text] [Related]
2. Enhancing tumor-specific intracellular delivering efficiency of cell-penetrating peptide by fusion with a peptide targeting to EGFR.
Nguyen LT; Yang XZ; Du X; Wang JW; Zhang R; Zhao J; Wang FJ; Dong Y; Li PF
Amino Acids; 2015 May; 47(5):997-1006. PubMed ID: 25655386
[TBL] [Abstract][Full Text] [Related]
3. Efficient drug delivery by novel cell-penetrating peptide derived from Midkine, with two heparin binding sites braced by a length-specific helix.
Chen Y; Li S; Zhao J; Cao X; Wang F
J Drug Target; 2022 Mar; 30(3):326-333. PubMed ID: 34708678
[TBL] [Abstract][Full Text] [Related]
4. The heparin-binding domain of HB-EGF as an efficient cell-penetrating peptide for drug delivery.
Luo Z; Cao XW; Li C; Wu MD; Yang XZ; Zhao J; Wang FJ
J Pept Sci; 2016 Nov; 22(11-12):689-699. PubMed ID: 27739168
[TBL] [Abstract][Full Text] [Related]
5. Improved breast cancer cell-specific intracellular drug delivery and therapeutic efficacy by coupling decoration with cell penetrating peptide and SP90 peptide.
Fan LQ; Du GX; Li PF; Li MW; Sun Y; Zhao LM
Biomed Pharmacother; 2016 Dec; 84():1783-1791. PubMed ID: 27899251
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the translocation properties of a new nuclear targeted penetrating peptide using two fluorescent markers.
Zhang R; Yang XZ; Wang JW; Fu LY; Zhao J; Wang FJ
J Drug Target; 2015 Jun; 23(5):444-52. PubMed ID: 25609361
[TBL] [Abstract][Full Text] [Related]
7. Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems.
Kondo E; Saito K; Tashiro Y; Kamide K; Uno S; Furuya T; Mashita M; Nakajima K; Tsumuraya T; Kobayashi N; Nishibori M; Tanimoto M; Matsushita M
Nat Commun; 2012 Jul; 3():951. PubMed ID: 22805558
[TBL] [Abstract][Full Text] [Related]
8. 15 years of ATTEMPTS: a macromolecular drug delivery system based on the CPP-mediated intracellular drug delivery and antibody targeting.
Ye J; Shin MC; Liang Q; He H; Yang VC
J Control Release; 2015 May; 205():58-69. PubMed ID: 25483423
[TBL] [Abstract][Full Text] [Related]
9. Enzyme-triggered, cell penetrating peptide-mediated delivery of anti-tumor agents.
He H; Sun L; Ye J; Liu E; Chen S; Liang Q; Shin MC; Yang VC
J Control Release; 2016 Oct; 240():67-76. PubMed ID: 26514292
[TBL] [Abstract][Full Text] [Related]
10. Smart Cell-Penetrating Peptide-Based Techniques for Intracellular Delivery of Therapeutic Macromolecules.
He Y; Li F; Huang Y
Adv Protein Chem Struct Biol; 2018; 112():183-220. PubMed ID: 29680237
[TBL] [Abstract][Full Text] [Related]
11. Screening and characterisation of a novel efficient tumour cell-targeting peptide derived from insulin-like growth factor binding proteins.
He ML; Lei J; Cao XW; Zhao J; Wang FJ
J Drug Target; 2023 Jun; 31(5):500-510. PubMed ID: 36974745
[TBL] [Abstract][Full Text] [Related]
12. Improved Protein Toxin Delivery Based on ATTEMPTS Systems.
Chen Y; Zhang M; Min KA; Wang H; Shin MC; Li F; Yang VC; Huang Y
Curr Drug Targets; 2018 Feb; 19(4):380-392. PubMed ID: 28260497
[TBL] [Abstract][Full Text] [Related]
13. Cell-penetrating peptides: strategies for anticancer treatment.
Raucher D; Ryu JS
Trends Mol Med; 2015 Sep; 21(9):560-70. PubMed ID: 26186888
[TBL] [Abstract][Full Text] [Related]
14. Cell penetrating peptides improve tumor delivery of cargos through neuropilin-1-dependent extravasation.
Kadonosono T; Yamano A; Goto T; Tsubaki T; Niibori M; Kuchimaru T; Kizaka-Kondoh S
J Control Release; 2015 Mar; 201():14-21. PubMed ID: 25592386
[TBL] [Abstract][Full Text] [Related]
15. Improved anticancer efficacy of doxorubicin mediated by human-derived cell-penetrating peptide dNP2.
Xiang Y; Shan W; Huang Y
Int J Pharm; 2018 Nov; 551(1-2):14-22. PubMed ID: 30205127
[TBL] [Abstract][Full Text] [Related]
16. Progress in tumour-targeted drug delivery based on cell-penetrating peptides.
Kong X; Xu J; Yang X; Zhai Y; Ji J; Zhai G
J Drug Target; 2022 Jan; 30(1):46-60. PubMed ID: 33944641
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.
Gautam A; Sharma M; Vir P; Chaudhary K; Kapoor P; Kumar R; Nath SK; Raghava GP
Eur J Pharm Biopharm; 2015 Jan; 89():93-106. PubMed ID: 25459448
[TBL] [Abstract][Full Text] [Related]
18. Novel cell-penetrating peptide-loaded nanobubbles synergized with ultrasound irradiation enhance EGFR siRNA delivery for triple negative Breast cancer therapy.
Jing H; Cheng W; Li S; Wu B; Leng X; Xu S; Tian J
Colloids Surf B Biointerfaces; 2016 Oct; 146():387-95. PubMed ID: 27388967
[TBL] [Abstract][Full Text] [Related]
19. Targeted Delivery of Cell Penetrating Peptide Virus-like Nanoparticles to Skin Cancer Cells.
Gan BK; Yong CY; Ho KL; Omar AR; Alitheen NB; Tan WS
Sci Rep; 2018 May; 8(1):8499. PubMed ID: 29855618
[TBL] [Abstract][Full Text] [Related]
20. Recombinant expression and purification of a MAP30-cell penetrating peptide fusion protein with higher anti-tumor bioactivity.
Lv Q; Yang XZ; Fu LY; Lu YT; Lu YH; Zhao J; Wang FJ
Protein Expr Purif; 2015 Jul; 111():9-17. PubMed ID: 25797209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
